Clinical Trial Update: Immune Response in Lung Cancer

View source ↗

Summary

A clinical trial evaluating immune response in lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Lithuanian University of Health Sciences | Conditions: Lung Cancer | Status: COMPLETED